High‐risk colorectal adenomas and serum insulin‐like growth factors

This study investigated the hypothesis that circulating levels of insulin‐like growth factor (IGF) I and its main binding protein (IGFBP‐3) predict for the presence of colorectal adenomas, surrogate markers of colorectal cancer risk.

[1]  C. Potten,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society Circulating Insulin-Like Growth Factor II and , 2000 .

[2]  A. Renehan,et al.  The prevalence and characteristics of colorectal neoplasia in acromegaly. , 2000, The Journal of clinical endocrinology and metabolism.

[3]  M. Pollak.  Insulin-like growth factor physiology and cancer risk. , 2000, European journal of cancer.

[4]  W. Willett,et al.  A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[5]  A. Renehan,et al.  Response: More About: Prospective Study of Colorectal Cancer Risk in Men and Plasma Levels of Insulin-Like Growth Factor (IGF)-I and IGF- Binding Protein-3 , 1999 .

[6]  G. Davey Smith,et al.  Growth hormone, IGF-I and cancer. Less intervention to avoid cancer? More intervention to prevent cancer? , 1999, The Journal of endocrinology.

[7]  F. Grodstein,et al.  Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis. , 1999, The American journal of medicine.

[8]  C. Mantzoros,et al.  Age, sex, and smoking are predictors of circulating insulin-like growth factor 1 and insulin-like growth factor-binding protein 3. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  R. McNally,et al.  Mortality and Cancer Incidence in Acromegaly: A Retrospective Cohort Study , 1998 .

[10]  David J Hunter,et al.  Circulating concentrations of insulin-like growth factor I and risk of breast cancer , 1998, The Lancet.

[11]  J. Wardle,et al.  Uptake, yield of neoplasia, and adverse effects of flexible sigmoidoscopy screening , 1998, Gut.

[12]  Meir J. Stampfer,et al.  Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study , 1998 .

[13]  S. Mohan,et al.  Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. , 1997, Endocrine reviews.

[14]  C. Mulrow,et al.  Colorectal cancer screening: clinical guidelines and rationale. , 1997, Gastroenterology.

[15]  P. Cohen,et al.  Insulin-like Growth Factor (IGF)-binding Protein-3 Induces Apoptosis and Mediates the Effects of Transforming Growth Factor-β1 on Programmed Cell Death through a p53- and IGF-independent Mechanism* , 1997, The Journal of Biological Chemistry.

[16]  C. Potten,et al.  Stimulation and inhibition of proliferation in the small intestinal crypts of the mouse after in vivo administration of growth factors. , 1995, Gut.

[17]  G A Colditz,et al.  A prospective study of family history and the risk of colorectal cancer. , 1994, The New England journal of medicine.

[18]  P. Amstad,et al.  Blockade of the insulin‐like growth‐factor‐I receptor inhibits growth of human colorectal cancer cells: Evidence of a functional IGF‐II‐mediated autocrine loop , 1994, International journal of cancer.

[19]  R. Ross,et al.  Endocrine and cardiac paracrine actions of insulin-like growth factor-I (IGF-I) during thyroid dysfunction in the rat: is IGF-I implicated in the mechanism of heart weight/body weight change during abnormal thyroid function? , 1993, Journal of molecular endocrinology.

[20]  J. Cuzick,et al.  Prevention of colorectal cancer by once-only sigmoidoscopy , 1993, The Lancet.

[21]  D. Leroith,et al.  Insulin-like Growth Factors in Health and Disease , 1992 .

[22]  J Cuzick,et al.  Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. , 1992, The New England journal of medicine.

[23]  L. Suardet,et al.  Growth regulation and co-stimulation of human colorectal cancer cell lines by insulin-like growth factor I, II and transforming growth factor alpha. , 1992, British Journal of Cancer.

[24]  K. Ho,et al.  Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women. , 1991, The Journal of clinical endocrinology and metabolism.